PACLITAXEL PLUS OR MINUS EPIRUBICIN AS SALVAGE TREATMENT IN METASTATIC BREAST-CANCER PATIENTS (PTS) RELAPSED AFTER HIGH-DOSE CHEMOTHERAPY (HDC) PLUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) TRANSPLANTATION
G. Lelli et al., PACLITAXEL PLUS OR MINUS EPIRUBICIN AS SALVAGE TREATMENT IN METASTATIC BREAST-CANCER PATIENTS (PTS) RELAPSED AFTER HIGH-DOSE CHEMOTHERAPY (HDC) PLUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 193-193